Drug of choice for rapid cyclers in manic–depressive psychosis is :
**Core Concept**
The question is testing the pharmacological management of bipolar disorder, specifically in patients who experience rapid cycling. Rapid cycling is characterized by four or more episodes of mania, hypomania, or depression within a 12-month period. The goal of treatment in such cases is to stabilize mood and prevent further episodes.
**Why the Correct Answer is Right**
Lithium is the drug of choice for rapid cyclers in manic–depressive psychosis due to its ability to stabilize mood and reduce the frequency of episodes. Lithium acts by inhibiting the reuptake of serotonin and norepinephrine, increasing the levels of these neurotransmitters in the synaptic cleft, and also by blocking the NMDA receptors. This leads to a decrease in the excitability of neurons and a subsequent reduction in the frequency and severity of mood episodes.
**Why Each Wrong Option is Incorrect**
* **Option A:** Haloperidol is an antipsychotic medication primarily used to treat schizophrenia and acute mania. It is not effective in preventing rapid cycling in bipolar disorder and can even worsen the condition due to its potential for extrapyramidal side effects and tardive dyskinesia.
* **Option B:** Carbamazepine is an anticonvulsant medication that is sometimes used in the treatment of bipolar disorder, particularly for patients who are resistant to lithium. However, it is not the first-line treatment for rapid cyclers and can have significant side effects, including agranulocytosis and aplastic anemia.
* **Option D:** Valproate is another anticonvulsant medication that is used in the treatment of bipolar disorder, particularly for patients who are resistant to lithium or have rapid cycling. However, it is not the preferred treatment for rapid cyclers due to its potential side effects, including hepatotoxicity and teratogenicity.
**Clinical Pearl / High-Yield Fact**
Lithium is the only medication that has been shown to reduce the frequency of episodes in rapid cyclers, and it should be considered as a first-line treatment in such cases.
**Correct Answer:** C. Lithium